Federal antitrust regulators issued a report describing the PBM industry as highly concentrated among a handful of companies that use their market power to put pressure on clients and competitors, and called for further investigation of an industry that has fought back against the probe. The 73-page Federal Trade Commission report, released Tuesday, doesn’t yet call for action such as breaking up pharmacy benefit managers from the insurers and drugstores they’ve merged with in recent years, or for putting limits on their business practices. But it does find that the investigation’s initial conclusions “urgently warrant further scrutiny and potential regulation.”
Read the full article: FTC Says PBMs ‘Exercise Vast Control’ over Healthcare, but Stops Short of Calling for Antitrust Action //
Source: https://endpts.com/ftc-says-pbms-exercise-vast-control-over-healthcare-in-long-awaited-report-on-drug-middlemen/